DxCP Task Force

Mission of the Task Force:

This task force was appointed by Academy President Dr. Hedi Hricak, in January of 2019, to provide an implementation plan. In doing so, identify relevant stake holders that can execute the recommendations within the Academy’s most recent white paper. This white paper stemmed from the Academy NIST Workshop in May of 2018. Advancing the Diagnostic Cockpit of the Future: An Opportunity to Improve Diagnostic Accuracy and Efficiency. Additionally, we will aim to also create new initiatives and collaborations among and between agencies or leverage existing ones.

Creation of the Task Force (view press release)

How can this Task Force be most effective towards the DXCP effort?

It was agreed that this task force is in a unique position to provide guidance, vision and a framework for best practices, a uniform place from where all groups can work and a source where direct outcomes can be tested. This task force can provide industry with the rare opportunity to receive significant, valuable input from the field (end-users) and still compete around that framework. This task force is not creating or developing an actual DxCP. The important challenges include; ensuring the practitioner is able to enhance their performance within the DxCP environment; standardize our perspectives to be of value to the entire community while preserving the competitive nature (IP); ensure the aspects of the DXCP that the Academy takes on will positively impact patient care; collaborate with the Administration and other government agencies where appropriate and in alignment with their priorities and; the identification of resources.

What's next for the Task Force?

The task force’s next focus is further defining the concept of the DxCP. This will require the task force to establish best practices of what industry, academics and government are doing today and how this collaboration can improve moving forward. Additionally, value and policy statements will be crafted.

Collecting and identifying all efforts, pilots and initiatives other societies are engaged in. Auditing our own community to identify current efforts and initiatives taking place will help avoid duplication and share activity collaboratively. The Academy will create a central webpage to house information such as: society logos, points of contact, details about the initiatives they’re working on to enable anyone to search for (and easily find) this information.

Task Force Members:

Mitch Schnall, MD, PhD
Dr. Schnall is the Eugene P. Pendergrass Professor & Chair of Radiology at the University of Pennsylvania. He received his undergraduate degree, medical degree, and Ph.D. from the University of Pennsylvania. He has been on the faculty of the radiology department at the University of Pennsylvania since 1991 and full professor since 2002. Dr. Schnall is an international leader in translational biomedical imaging research. Through his career he has worked across the interface between basic imaging science and clinical medicine. His work has lead to fundamental changes in the imaging approaches to breast and prostate cancer. In addition, he has had a significant influence on emerging technologies such as optical imaging. Dr. Schnall has been elected as a member of the American Society Clinical Investigation and the Association of American Physicians. He has been the principal investigator of numerous team science initiatives.

He also maintains active membership in the American Society of Clinical Oncology (ASCO), the Radiological Society of North America (RSNA), and other research and professional organizations in order to ensure effective integration of radiology research with other medical disciplines. Dr. Schnall has played a critical role in efforts to organize cancer clinical and translational imaging research in the US.

He served ACRIN Deputy Chair from 1999-2007. In 2008 he assumed the role of ACRIN Chair. He serves as Co-PI of the Center for Magnetic Resonance and Optical Imaging, an NIH funded regional resource at the University of Pennsylvania.

Sara Brenner, MD, MPH

Dr. Brenner’s research and initiatives aim to develop novel nanotechnology applications in the life sciences, including medicine and public health. She is also leading health and safety research initiatives related to nanoparticle and nanomaterial exposures in the workplace, consumer marketplace, and environment. Dr. Brenner is addressing gaps in our understanding of the safety and risk associated with the unique characteristics of nanoscale materials by incorporating theory from many disciplines such as physics, engineering, biology, genetics, medicine, public health, epidemiology, and environmental science. As part of these efforts, she is advancing risk assessment and reduction strategies for occupational exposures, monitoring of materials that may impact population health and public safety, and the development of industrial practice standards for product safety. Dr. Brenner is working proactively with collaborators and partners to develop monitoring and surveillance techniques to assess the environmental and ecological impact as well as the biopersistence of engineered nanomaterials in the Capital District. Her team is building a framework to employ custom-tailored strategies to mitigate potential risks associated with nanotechnology-based products that are currently on the market as well as those under development.

Dr. Brenner is currently on sabbatical in Washington DC, serving as a Senior Policy Advisor in the White House Office of Science and Technology Policy with a broad portfolio in biomedical science and health technology arenas. Working in the Executive Office of the President, she provides expert advice, guidance, and direction on the nation’s highest scientific and technological priorities spanning biotechnology, medicine, health care, education, and the scientific enterprise at large.

Renee L. Cruea, MPA

Renee Baglione Cruea, MPA, is the Executive Director of The Academy for Radiology & Biomedical Imaging Research in Washington DC. Renee joined the Academy in 1998 as Government Relations Director and became Executive Director in 2007. Prior to joining the Academy, Renee worked as an associate with Rae Evans & Associates, a DC lobbying group. She is also the President and Founder of “Sugar Mommas”, an activist group for women who have Type1 diabetes.

The Academy advocates on behalf of the imaging research community to increase awareness about the impact that medical imaging technology has on patient care, and promotes support for federal investment into imaging research at the National Institutes of Health (NIH) and across government agencies. The Academy led successful efforts to create both the National Institute of Biomedical Imaging and Bioengineering (NIBIB) at the NIH and the Interagency Working Group on Medical Imaging (IWGMI) with in the White House Office of Science and Technology Policy (OSTP). The Academy’s division, the Coalition for Imaging & Bioengineering Research (CIBR) is a diverse coalition of imaging stakeholders dedicated to education and advocacy for imaging research funding. Membership within the Academy includes patient advocacy groups, academic radiology departments, imaging societies, and device manufacturers.

Cruea holds a Masters in Public Administration from Central Michigan and a Bachelor in Political Science and History from St. Bonaventure University. Cruea is a member of the American Society of Association Executives (ASAE).

Janet F. Eary, MD
Dr. Eary received her Bachelor of Science degree at the University of Michigan and Doctor of Medicine degree from the Michigan State University College of Human Medicine. Her postdoctoral training was completed at the University of Washington in Anatomic Pathology, Laboratory Medicine, and Nuclear Medicine, medical specialties in which she holds Medical Specialty Board Certifications. She has also participated as a member of the American Board of Nuclear Medicine. Her academic career began at the University of Washington School of Medicine (UWMC), where she was professor of Radiology, Pathology, and Orthopedics and held a faculty position in the University of Washington Graduate School. While at UWMC, she also served as Director for the Division of Nuclear Medicine and the Molecular Imaging Center and was a full member at the Fred Hutchinson Cancer Research Center where she was the creator and leader for the Cancer Imaging Program in the NCI Comprehensive Cancer Center. She also was course coordinator for the seminar in Molecular Medicine and served on several institutional committees. Dr. Eary has been a research principal investigator and program leader continuously throughout her career which began in experimental therapy with radiopharmaceuticals and was a pioneer in molecular imaging. She has expertise in molecular imaging, radionuclide therapy, translational studies, clinical trial design, imaging basic science and image analysis which remain as her research interests. Dr. Eary has published over 160 articles in these areas and is also the author of a radionuclide therapy book, numerous book chapters, educational materials, and editorials. From 2014 to 2016, Dr. Eary was a professor of Radiology and Surgery at the University of Alabama at Birmingham (UAB) School of Medicine and Graduate School, and Radiology Vice Chair of Clinical Research. She was also a member of the UAB NCI Comprehensive Cancer Center Experimental Therapeutics Program. Presently, Dr. Eary is a frequent lecturer on advanced imaging topics in the U.S. and internationally.

At NCI, Dr. Eary brings her background as a physician scientist and clinician to lead the NCI/CIP to achieve program goals to advance cancer imaging and imaging community contributions to improving outcomes for cancer patients.

Elizabeth Krupinski, PhD

Krishna Kandarpa, M.D., Ph.D., is a cardiovascular and interventional radiologist, who is Director of Research Sciences and Strategic Directions at NIBIB/NIH.

Most recently, he was Chief Medical Officer/Chief Scientific Officer/EVP-R&D at Delcath Systems, Inc., New York, NY, which markets a combination device/drug treatment for cancers in the liver.

Prior to this, he was tenured Professor and Chair of the Department of Radiology at the University of Massachusetts Medical School and Radiologist-in-Chief at the UMass Memorial Medical Center. Earlier, he was at the Weill Medical College of Cornell University, where he was a Professor of Radiology and Chief of Service and Director of the Division of Cardiovascular & Interventional Radiology at The New York Presbyterian Hospital (Cornell), when he simultaneously held an adjunct professorship at the College of Physicians and Surgeons of Columbia University.

He embarked on his academic career at Harvard Medical School and was an Associate Professor of Radiology, co-director of Cardiovascular & Interventional Radiology and the Vascular Center, at the Brigham and Women’s Hospital, Boston, MA. While there, he was also on the faculty of the Harvard-Massachusetts Institute of Technology Health Sciences and Technology Program.

Krishna Kandarpa, M.D., Ph.D.

Dr. Krupinski is a Professor at Emory University in the Departments of Radiology & Imaging Sciences where she is the Vice-Chair for Research, and has joint appointments with Psychology and Biomedical Engineering. She received her BA from Cornell, MA from Montclair State and PhD from Temple, all in Experimental Psychology. Her interests are in medical image perception, observer performance, medical decision making, and human factors. She is also Associate Director of Evaluation for the Arizona Telemedicine Program and Director of the Southwest Telehealth Resource Center (SWTRC). She has published extensively in these areas, and has presented at conferences nationally and internationally. She is Past Chair of the SPIE Medical Imaging Conference, Past President of the American Telemedicine Association, President of the Medical Image Perception Society, and Past Chair of the Society for Imaging Informatics in Medicine. She serves on a number of editorial boards for both radiology and telemedicine journals and is the Co-Editor of the Journal of Telemedicine & Telecare. She serves regularly as a grant reviewer for the NIH, DoD, TATRC and other federal, state and international funding agencies and has served as a member of a number of FDA review panels.

Rich Mather, PhD

Rich Mather leads a team dedicated to clinical collaborations, research trials, and clinical applications development at the Toshiba Medical Research, USA.

Etta D. Pisano, MD

Dr. Etta Pisano has served as the Vice Chair for Research in the Department of Radiology at Beth Israel Deaconess Medical School and is on the faculty at Harvard Medical School since November 2015. She also has served as the Senior Director for Research Development at the Center for Research and Innovation at the American College of Radiology since July 2015. She is also currently serving as the Study Chair for The Tomosynthesis Mammographic Imaging Screening Trial, a National Cancer Institute-funded clinical trial under the auspices of the ECOG-ACRIN research base, which will enroll over 165,000 women in 150 sites in the US and Canada.

Prior to her current roles, she served at the Medical University of South Carolina (MUSC) as Vice President for Medical Affairs and Dean of the College of Medicine and as Vice Dean for Academic Affairs at the University of North Carolina (UNC) School of Medicine, Kenan Professor of Radiology and Biomedical Engineering, Director of the UNC Biomedical Research Imaging Center, and Director of the N.C. Translational and Clinical Sciences Institute. She is an expert in breast cancer imaging and, for almost 16 years, she served as the Chief of Breast Imaging at UNC Hospitals. Her undergraduate degree in Philosophy is from Dartmouth College and her medical degree is from Duke University. Etta’s professional interests center around the development, application and testing of imaging technology for the early detection and diagnosis of breast cancer and other breast problems.

Etta was born in New York City and was raised in the suburbs of Philadelphia. After completing a rotating internship in a community-based program in Pensacola, Florida, she completed her radiology residency at Beth Israel Hospital of Harvard Medical School. After her residency, she spent a year as Chief of Breast Imaging and Instructor in Radiology at the same institution. She is a Past President of the Association of University Radiologists and the American Association for Women Radiologists. Etta served as the Principal Investigator of the largest clinical trial ever run by a radiologist, the Digital Mammographic Imaging Screening Trial (DMIST), which enrolled 49,528 women in a study comparing digital to film mammography, the results of which were published in 2005 in the New England Journal of Medicine. In 2003, she was appointed the first Director of the UNC Biomedical Research Imaging Center, a core facility that develops and commercializes new imaging technologies.

In 2008 Etta was elected as a member of the Institute of Medicine of the National Academy of Sciences. She is a recipient of the Gold Medal from the Association of University Radiologists (2010), the American Roentgen Ray Society (2012), and the Radiologic Society of North America (2014) and of the Alice Ettinger Distinguished Achievement Award from the American Association for Women Radiologists (2012). At MUSC and UNC, Etta received honors for her work on behalf of faculty diversity. Etta received the National Women’s History Museum Helen Taussig Living Legacy Award in 2013.

Steven Seltzer, MD

Dr. Seltzer’s clinical interests are in the field of abdominal imaging, particularly advanced applications of helical CT. He has been involved in numerous projects aimed at improving the quality, safety, productivity and cost-effectiveness of radiology services for more than two decades, including spending a 3-month sabbatical as a member of Brooking’s Institution’s Health Policy group, working on two contemporary projects related to federal health care reform.

Bram Stolk, PhD, MBA
Brian Zimmerman, PhD
Go to Top